Compare UPWK & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UPWK | OPK |
|---|---|---|
| Founded | 1998 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.0B |
| IPO Year | 2018 | 2011 |
| Metric | UPWK | OPK |
|---|---|---|
| Price | $8.81 | $1.63 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 11 | 3 |
| Target Price | ★ $22.73 | $1.60 |
| AVG Volume (30 Days) | ★ 3.7M | 2.6M |
| Earning Date | 05-07-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.44 | N/A |
| Revenue | ★ $787,784,000.00 | $606,879,000.00 |
| Revenue This Year | $9.06 | N/A |
| Revenue Next Year | $13.57 | $4.24 |
| P/E Ratio | $21.06 | ★ N/A |
| Revenue Growth | ★ 2.40 | N/A |
| 52 Week Low | $7.44 | $0.98 |
| 52 Week High | $22.84 | $1.73 |
| Indicator | UPWK | OPK |
|---|---|---|
| Relative Strength Index (RSI) | 56.52 | 69.01 |
| Support Level | $8.48 | $1.12 |
| Resistance Level | $9.79 | $1.73 |
| Average True Range (ATR) | 0.30 | 0.06 |
| MACD | 0.07 | 0.02 |
| Stochastic Oscillator | 89.06 | 81.71 |
Upwork Inc is a United States-based company that operates an online marketplace that enables businesses to find and work with skilled independent professionals. The company develops platform for hiring and freelancing purposes and connects businesses with AI-enabled talent across every on-demand work type, including freelance, agency, fractional, and payrolled. The business generates revenue from Talent and Clients across the USA, India, Pakistan, the Philippines and the rest of the world. Maximum revenue of the company is derived from Talent segment.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.